title: Gallbladder perforation related to bevacizumab.
authors.affiliation: Department of Internal Medicine, Yeditepe University Hospital, İstanbul, Turkey. Electronic address: mehmet.ozturk@yeditepe.edu.tr.
authors.forename: Mehmet Akif
authors.initials: MA
authors.lastname: Ozturk
authors.forename: Murat
authors.initials: M
authors.lastname: Kalayci
authors.forename: Basak
authors.initials: B
authors.lastname: Oyan
mesh_terms: D015746:Abdominal Pain / Q000209:etiology; D000038:Abscess / Q000628:therapy; D000368:Aged; D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D001201:Ascites / Q000628:therapy; D000068258:Bevacizumab; D002763:Cholecystectomy; D004322:Drainage; D005334:Fever / Q000209:etiology; D005705:Gallbladder Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000601:surgery; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D014839:Vomiting / Q000209:etiology
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab